136 related articles for article (PubMed ID: 36155165)
1. Role of gremlin-1 in the pathophysiology of the adipose tissues.
Grillo E; Ravelli C; Colleluori G; D'Agostino F; Domenichini M; Giordano A; Mitola S
Cytokine Growth Factor Rev; 2023 Feb; 69():51-60. PubMed ID: 36155165
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.
Chiodelli P; Mitola S; Ravelli C; Oreste P; Rusnati M; Presta M
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e116-27. PubMed ID: 21921258
[TBL] [Abstract][Full Text] [Related]
3. The binding of the bone morphogenetic protein antagonist gremlin to kidney heparan sulfate: Such binding is not essential for BMP antagonism.
Tatsinkam AJ; Rune N; Smith J; Norman JT; Mulloy B; Rider CC
Int J Biochem Cell Biol; 2017 Feb; 83():39-46. PubMed ID: 27979781
[TBL] [Abstract][Full Text] [Related]
4. Gremlin-1 induces BMP-independent tumor cell proliferation, migration, and invasion.
Kim M; Yoon S; Lee S; Ha SA; Kim HK; Kim JW; Chung J
PLoS One; 2012; 7(4):e35100. PubMed ID: 22514712
[TBL] [Abstract][Full Text] [Related]
5. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis.
Myllärniemi M; Lindholm P; Ryynänen MJ; Kliment CR; Salmenkivi K; Keski-Oja J; Kinnula VL; Oury TD; Koli K
Am J Respir Crit Care Med; 2008 Feb; 177(3):321-9. PubMed ID: 17975199
[TBL] [Abstract][Full Text] [Related]
6. Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1.
Mitola S; Ravelli C; Corsini M; Gianoncelli A; Galvagni F; Ballmer-Hofer K; Presta M; Grillo E
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163075
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic proteins in inflammation, glucose homeostasis and adipose tissue energy metabolism.
Grgurevic L; Christensen GL; Schulz TJ; Vukicevic S
Cytokine Growth Factor Rev; 2016 Feb; 27():105-18. PubMed ID: 26762842
[TBL] [Abstract][Full Text] [Related]
8. Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway.
Lavoz C; Alique M; Rodrigues-Diez R; Pato J; Keri G; Mezzano S; Egido J; Ruiz-Ortega M
J Pathol; 2015 Aug; 236(4):407-20. PubMed ID: 25810250
[TBL] [Abstract][Full Text] [Related]
9. Gremlin and renal diseases: ready to jump the fence to clinical utility?
Mezzano S; Droguett A; Lavoz C; Krall P; Egido J; Ruiz-Ortega M
Nephrol Dial Transplant; 2018 May; 33(5):735-741. PubMed ID: 28992340
[TBL] [Abstract][Full Text] [Related]
10. Gremlin-1: An endogenous BMP antagonist induces epithelial-mesenchymal transition and interferes with redifferentiation in fetal RPE cells with repeated wounds.
Li D; Yuan D; Shen H; Mao X; Yuan S; Liu Q
Mol Vis; 2019; 25():625-635. PubMed ID: 31700227
[TBL] [Abstract][Full Text] [Related]
11. Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist.
Grillo E; Ravelli C; Corsini M; Ballmer-Hofer K; Zammataro L; Oreste P; Zoppetti G; Tobia C; Ronca R; Presta M; Mitola S
Oncotarget; 2016 Jun; 7(23):35353-68. PubMed ID: 27174917
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.
Tardif G; Hum D; Pelletier JP; Boileau C; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2004 Aug; 50(8):2521-30. PubMed ID: 15334466
[TBL] [Abstract][Full Text] [Related]
13. Identification of direct negative cross-talk between the SLIT2 and bone morphogenetic protein-Gremlin signaling pathways.
Tumelty KE; Higginson-Scott N; Fan X; Bajaj P; Knowlton KM; Shamashkin M; Coyle AJ; Lu W; Berasi SP
J Biol Chem; 2018 Mar; 293(9):3039-3055. PubMed ID: 29317497
[TBL] [Abstract][Full Text] [Related]
14. The Novel Adipokine Gremlin 1 Antagonizes Insulin Action and Is Increased in Type 2 Diabetes and NAFLD/NASH.
Hedjazifar S; Khatib Shahidi R; Hammarstedt A; Bonnet L; Church C; Boucher J; Blüher M; Smith U
Diabetes; 2020 Mar; 69(3):331-341. PubMed ID: 31882566
[TBL] [Abstract][Full Text] [Related]
15. Mapping the heparin-binding site of the BMP antagonist gremlin by site-directed mutagenesis based on predictive modelling.
Tatsinkam AJ; Mulloy B; Rider CC
Biochem J; 2015 Aug; 470(1):53-64. PubMed ID: 26251446
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts.
Pereira RC; Economides AN; Canalis E
Endocrinology; 2000 Dec; 141(12):4558-63. PubMed ID: 11108268
[TBL] [Abstract][Full Text] [Related]
17. The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb.
Merino R; Rodriguez-Leon J; Macias D; Gañan Y; Economides AN; Hurle JM
Development; 1999 Dec; 126(23):5515-22. PubMed ID: 10556075
[TBL] [Abstract][Full Text] [Related]
18. Expression of gremlin, a bone morphogenetic protein antagonist,is associated with vascular calcification in uraemia.
Jara A; Chacón C; Burgos ME; Droguett A; Valdivieso A; Ortiz M; Troncoso P; Mezzano S
Nephrol Dial Transplant; 2009 Apr; 24(4):1121-9. PubMed ID: 19028757
[TBL] [Abstract][Full Text] [Related]
19. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
[TBL] [Abstract][Full Text] [Related]
20. Molecular Regulation of Notch Signaling by Gremlin.
Marquez-Exposito L; Cantero-Navarro E; R Rodrigues-Diez R; Orejudo M; Tejera-Muñoz A; Tejedor L; Rayego-Mateos S; Rández-Carbayo J; Santos-Sanchez L; Mezzano S; Lavoz C; Ruiz-Ortega M
Adv Exp Med Biol; 2020; 1227():81-94. PubMed ID: 32072500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
